moxifloxacin has been researched along with warfarin in 14 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | moxifloxacin (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Ward, KW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chang, SW; Elbe, DH | 1 |
Arnold, LM; Ng, TM; Nissen, LR | 1 |
Carroll, DG; Carroll, DN | 1 |
Candevir, A; Cayli, M; Kurtaran, B; Sümbül, Z; Yildiz, F | 1 |
Berube, C; Lee, R; Wen, A | 1 |
Lee, WC; Yew, KL | 1 |
Chao, CM; Lai, CC; Lin, SH | 1 |
2 review(s) available for moxifloxacin and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Interactions between warfarin and three commonly prescribed fluoroquinolones.
Topics: Aza Compounds; Ciprofloxacin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Humans; International Normalized Ratio; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Warfarin | 2008 |
12 other study(ies) available for moxifloxacin and warfarin
Article | Year |
---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Moxifloxacin-warfarin interaction: a series of five case reports.
Topics: Aged; Aged, 80 and over; Aza Compounds; Drug Interactions; Female; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Retrospective Studies; Warfarin | 2005 |
Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction.
Topics: Aged; Anticoagulants; Aza Compounds; Drug Interactions; Female; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Warfarin | 2005 |
A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve.
Topics: Aged; Anti-Infective Agents; Anticoagulants; Aza Compounds; Bioprosthesis; Blood Coagulation; Blood Component Transfusion; Drug Interactions; Endocarditis; Fluoroquinolones; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Male; Mitral Valve; Moxifloxacin; Quinolines; Warfarin | 2008 |
Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
Topics: Acetaminophen; Adjuvants, Immunologic; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Infective Agents; Anticoagulants; Antifibrinolytic Agents; Aza Compounds; BCG Vaccine; Drug Interactions; Fluoroquinolones; Humans; International Normalized Ratio; Male; Moxifloxacin; Quinolines; Urinary Bladder Neoplasms; Vitamin K 1; Warfarin | 2011 |
Moxifloxacin-warfarin interaction.
Topics: Anti-Infective Agents; Anticoagulants; Aza Compounds; Drug Interactions; Female; Fluoroquinolones; Heart Valve Diseases; Humans; International Normalized Ratio; Middle Aged; Mitral Valve; Moxifloxacin; Quinolines; Tricuspid Valve; Warfarin | 2012 |
Abdominal wall hematoma and hemoperitoneum in an individual with concomitant use of warfarin and moxifloxacin.
Topics: Abdominal Wall; Aged; Anti-Bacterial Agents; Anticoagulants; Aza Compounds; Blood Coagulation Tests; Drug Interactions; Drug Therapy, Combination; Female; Fluoroquinolones; Heart Valve Prosthesis; Hematoma; Hemoperitoneum; Humans; Mitral Valve Insufficiency; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Thromboembolism; Tomography, X-Ray Computed; Warfarin | 2013 |